Alembic Pharmaceuticals reports 12% rise in Q1 consolidated net profit

08 Aug 2024 Evaluate

Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2024 (Q1FY25). 

The company has reported 80.65% rise in net profit at Rs 176.19 crore for Q1FY25 as compared to Rs 97.53 crore for the same quarter in the previous year. Total income of the company increased by 10.01% at Rs 1478.70 crore for Q1FY25 as compared to Rs 1344.12 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 11.70% rise in its net profit at Rs 134.71 crore for the quarter ended June 30, 2024 as compared to Rs 120.60 crore for the same quarter in the previous year. Total income of the company increased by 4.41% at Rs 1563.83 crore for Q1FY25 as compared to Rs 1497.81 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

1038.20 -4.40 (-0.42%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.